Celyad Oncology SA
XBRU:CYAD

Watchlist Manager
Celyad Oncology SA Logo
Celyad Oncology SA
XBRU:CYAD
Watchlist
Price: 0.4745 EUR -5.1% Market Closed
Market Cap: 19.7m EUR
Have any thoughts about
Celyad Oncology SA?
Write Note

Celyad Oncology SA
Depreciation & Amortization

Last Value
3-Years 3-Y CAGR
5-Years 5-Y CAGR
10-Years 10-Y CAGR
Quarterly
Annual
TTM
|

Celyad Oncology SA
Depreciation & Amortization Peer Comparison

Comparables:
M
MDXH
GLPG
OXUR

Competitive Depreciation & Amortization Analysis
Latest Figures & CAGR of Competitors

Company Depreciation & Amortization CAGR 3Y CAGR 5Y CAGR 10Y
Celyad Oncology SA
XBRU:CYAD
Depreciation & Amortization
€626k
CAGR 3-Years
-29%
CAGR 5-Years
-14%
CAGR 10-Years
N/A
M
MDxHealth SA
NASDAQ:MDXH
Depreciation & Amortization
$7.1m
CAGR 3-Years
31%
CAGR 5-Years
18%
CAGR 10-Years
37%
Galapagos NV
AEX:GLPG
Depreciation & Amortization
€61.8m
CAGR 3-Years
26%
CAGR 5-Years
48%
CAGR 10-Years
N/A
Oxurion NV
XBRU:OXUR
Depreciation & Amortization
€268k
CAGR 3-Years
-40%
CAGR 5-Years
-41%
CAGR 10-Years
N/A

See Also

What is Celyad Oncology SA's Depreciation & Amortization?
Depreciation & Amortization
626k EUR

Based on the financial report for Jun 30, 2024, Celyad Oncology SA's Depreciation & Amortization amounts to 626k EUR.

What is Celyad Oncology SA's Depreciation & Amortization growth rate?
Depreciation & Amortization CAGR 5Y
-14%

Over the last year, the Depreciation & Amortization growth was -28%. The average annual Depreciation & Amortization growth rates for Celyad Oncology SA have been -29% over the past three years , -14% over the past five years .

Back to Top